vimarsana.com
Home
Live Updates
Tiziana Life Sciences Announces Foralumab Dosing of Four New
Tiziana Life Sciences Announces Foralumab Dosing of Four New
Tiziana Life Sciences Announces Foralumab Dosing of Four New Patients in the Expanded Access Program for Multiple Sclerosis
NEW YORK, Nov. 30, 2023 -- Tiziana Life Sciences Ltd. , a biotechnology company developing breakthrough immunomodulation therapies via novel routes of drug delivery, today announced that the...
Related Keywords
Paul Spencer ,
Irina Koffler ,
Gabriele Cerrone ,
Nasdaq ,
Tiziana Life Sciences Ltd ,
Globenewswire Inc ,
Lifesci Advisors ,
Tea Program ,
Brigham Healthcare System Expanded Access Ea Program ,
Tiziana Life Sciences ,
Business Development ,
Access Program ,
Life Sciences ,
Life Science ,
Confirmatory Evidence ,
Investor Relations ,
Sci Advisors ,
Markets ,